Iterum Therapeutics Plc (ITRM) Tops Q4 EPS by 63c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.52), $0.63 better than the analyst estimate of ($1.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c